Keros Therapeutics
KROS
#4177
Rank
ยฃ1.66 B
Marketcap
ยฃ44.25
Share price
2.87%
Change (1 day)
75.11%
Change (1 year)

Revenue for Keros Therapeutics (KROS)

Revenue in 2024 (TTM): ยฃ0.21 M

According to Keros Therapeutics's latest financial reports the company's current revenue (TTM) is ยฃ0.2 M. In 2023 the company made a revenue of ยฃ0.11 M an increase over the revenue in the year 2022 that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Keros Therapeutics from 2019 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.21 M80.37%
2023 ยฃ0.11 M
2022 N/A-100%
2021 ยฃ14.85 M
2020 N/A-100%
2019 ยฃ7.53 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA